What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Internal medicine
His primary areas of study are Immunology, Leishmania donovani, Antigen, Spleen and Visceral leishmaniasis.
His work in Immunity, Leishmaniasis, Immune system, Cytokine and T cell are all subfields of Immunology research.
Leishmania donovani is a subfield of Leishmania that Paul M. Kaye tackles.
His Leishmania research incorporates elements of Macrophage, Monoclonal antibody, Intracellular parasite and Virology.
His Antigen research is multidisciplinary, relying on both Tumor necrosis factor alpha, Leishmania infantum, Antibody and T cell immunology.
The various areas that he examines in his Spleen study include Immunotherapy and Pathology.
His most cited work include:
- Leishmaniasis: complexity at the host–pathogen interface (553 citations)
- The role of dendritic cells in the induction and regulation of immunity to microbial infection. (287 citations)
- Leishmaniasis: new approaches to disease control (249 citations)
What are the main themes of his work throughout his whole career to date?
Paul M. Kaye mainly focuses on Immunology, Leishmania donovani, Visceral leishmaniasis, Immune system and T cell.
Paul M. Kaye frequently studies issues relating to Leishmania and Immunology.
His work in Leishmania donovani covers topics such as Bone marrow which are related to areas like Haematopoiesis and Stromal cell.
As part of one scientific family, he deals mainly with the area of Visceral leishmaniasis, narrowing it down to issues related to the Interleukin 10, and often Interleukin 4.
His T cell research includes elements of Molecular biology, Dendritic cell, CD8 and Cell biology.
His research integrates issues of Leishmania major, Disease and Virology in his study of Leishmaniasis.
He most often published in these fields:
- Immunology (62.07%)
- Leishmania donovani (30.05%)
- Visceral leishmaniasis (25.12%)
What were the highlights of his more recent work (between 2016-2021)?
- Visceral leishmaniasis (25.12%)
- Immunology (62.07%)
- Immune system (22.17%)
In recent papers he was focusing on the following fields of study:
Paul M. Kaye mostly deals with Visceral leishmaniasis, Immunology, Immune system, Leishmaniasis and Leishmania donovani.
His Visceral leishmaniasis study integrates concerns from other disciplines, such as Internal medicine, Clinical trial, BALB/c, Host and Vaccination.
His specific area of interest is Immunology, where Paul M. Kaye studies Inflammation.
When carried out as part of a general Immune system research project, his work on Immunity is frequently linked to work in Context, therefore connecting diverse disciplines of study.
Paul M. Kaye has researched Leishmaniasis in several fields, including Transmission, Virology, Environmental health and Disease.
His Leishmania donovani research integrates issues from Zoology, Vector, Anemia and Bone marrow.
Between 2016 and 2021, his most popular works were:
- A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH (57 citations)
- Skin parasite landscape determines host infectiousness in visceral leishmaniasis (31 citations)
- In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in mice (30 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Internal medicine
His primary scientific interests are in Immunology, Visceral leishmaniasis, Leishmania donovani, Immune system and Leishmaniasis.
Particularly relevant to T cell is his body of work in Immunology.
Paul M. Kaye interconnects Macrophage, Disease and Leishmania in the investigation of issues within Visceral leishmaniasis.
His Leishmania donovani research is multidisciplinary, incorporating elements of Haematopoiesis and Bone marrow.
His Immune system study incorporates themes from Spleen, Immunopathology and Vaccination.
His Leishmaniasis research focuses on subjects like Virology, which are linked to Gene, Microbiology, Antigen and Pathogen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
